Shares of Rentokil Initial plc (LON:RTO – Get Free Report) hit a new 52-week low during trading on Thursday . The stock traded as low as GBX 315.30 ($4.09) and last traded at GBX 320 ($4.15), with a volume of 10226604 shares trading hands. The stock had previously closed at GBX 323.40 ($4.19).
Analyst Upgrades and Downgrades
RTO has been the topic of several recent analyst reports. JPMorgan Chase & Co. decreased their price target on Rentokil Initial from GBX 440 ($5.71) to GBX 430 ($5.58) and set a “neutral” rating on the stock in a research note on Tuesday, January 14th. Deutsche Bank Aktiengesellschaft reduced their price objective on Rentokil Initial from GBX 485 ($6.29) to GBX 465 ($6.03) and set a “buy” rating on the stock in a research note on Friday, March 7th.
Check Out Our Latest Report on Rentokil Initial
Rentokil Initial Trading Down 1.1 %
Rentokil Initial (LON:RTO – Get Free Report) last posted its quarterly earnings data on Thursday, March 6th. The company reported GBX 21.25 ($0.28) EPS for the quarter. Rentokil Initial had a return on equity of 9.50% and a net margin of 7.25%. As a group, equities analysts forecast that Rentokil Initial plc will post 25.8725561 EPS for the current year.
Rentokil Initial Company Profile
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers.
Further Reading
- Five stocks we like better than Rentokil Initial
- 3 Best Fintech Stocks for a Portfolio Boost
- Ramaco Resources Pins Hopes on Coal’s Untapped Potential
- Energy and Oil Stocks Explained
- NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
- Growth Stocks: What They Are, What They Are Not
- Why Energy Transfer Belongs on Your Watchlist
Receive News & Ratings for Rentokil Initial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rentokil Initial and related companies with MarketBeat.com's FREE daily email newsletter.